|Jerusalem Life Science Bulletin - Highlights of Jerusalem's Life Science Industry Q3 2011|
In September BioJerusalem took part in an Entrepreneurship Symposium organized by Bioabroad. The Symposium took place in three major U.S life sciences hubs; Boston, Washington D.C. and San Francisco. The purpose of the Symposium was to meet with entrepreneurs who are interested in establishing their businesses in Israel and to provide them with all of the relevant information. Alongside BioJerusalem, the panel of experts included representatives from the Ministry of Industry, Trade and Labor, the Ministry of Immigration Absorption, and Tax and Legal experts.
The Jerusalem Biomed sector was chosen as the focus of The Jerusalem Economic Forum hosted by Jerusalem Mayor, Nir Barkat. The forum convenes several times per year, focusing each time on a topic of relevance to the city’s economic development. I would like to thank our panel members, Dr. Aharon Schwartz, Prof. Shlomo Mor-Yosef and Prof. Ariel Darvasi, for a very interesting panel discussion.
With best wishes,
Chen Levin, Executive Director of BioJerusalem,
The Jerusalem Development Authority
BioLineRx Announces First Subject Enrolled in Phase I Clinical Trial of BL-1021 for Neuropathic Pain
Intec Pharma jumps on positive Parkinson's results
BioLineRx Announces Positive Preliminary Results from Phase I Clinical Trial of BL-1021 for Neuropathic Pain
FDA approves Teva's Jerusalem facility
Yissum Introduces Novel Markers for Brain Cancer Survival Prognosis and a New Treatment Method for the Disease
Path to cure for diabetes opens
BioMed SA strikes deal with BioJerusalem
Hebrew University's Yissum teams with Shaare Zedek Hospital
BioMarCare Technologies Ltd. Receives a $900k Grant for a Joint Project with Ariadne Inc.
BioLineRx In-Licenses BL-7050
Hadasit launches Jewish-Arab biomed incubator in Galilee
"Large drug companies are stuck in a rut"
BioLineRx Announces Plans to Launch ADR Program on NASDAQ
BioLineRx ADRs Issues
Chief Scientist approves NIS 5.9m Biocancell pancreatic cancer trial
Intec Pharma raises NIS 10.8m in rights issue
Please visit www.biojerusalem.org.il or contact us for more information on how BioJerusalem can assist your business.
The International Conference on Integrative Medicine
For Previous issues of the Life Science Bulletin Click here.
High Tech Village, Bldg. 1-1
Edmond Safra Campus
Givat Ram, P.O.Box 39026
Jerusalem 91390, Israel
For more information on the latest life science activities in Jerusalem and how BioJerusalem can assist your business, visit us at www.biojerusalem.org.il or contact Chen Levin, Executive Director, BioJerusalem, the Jerusalem Development Authority at email@example.com.
If you no longer wish to receive the Jerusalem Life Science Bulletin, please unsubscribe
by replying to this email with the word 'remove' in your email message subject line.